Source:http://linkedlifedata.com/resource/pubmed/id/20958055
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
2010-11-4
|
pubmed:abstractText |
Neuronal nitric oxide synthase (nNOS) represents an important therapeutic target for the prevention of brain injury and the treatment of various neurodegenerative disorders. A series of trans-substituted amino pyrrolidinomethyl 2-aminopyridine derivatives (8-34) was designed and synthesized. A structure-activity relationship analysis led to the discovery of low nanomolar nNOS inhibitors ((±)-32 and (±)-34) with more than 1000-fold selectivity for nNOS over eNOS. Four enantiomerically pure isomers of 3'-[2''-(3'''-fluorophenethylamino)ethoxy]pyrrolidin-4'-yl}methyl}-4-methylpyridin-2-amine (4) also were synthesized. It was found that (3'R,4'R)-4 can induce enzyme elasticity to generate a new "hot spot" for ligand binding. The inhibitor adopts a unique binding mode, the same as that observed for (3'R,4'R)-3'-[2''-(3'''-fluorophenethylamino)ethylamino]pyrrolidin-4'-yl}methyl}-4-methylpyridin-2-amine ((3'R,4'R)-3) (J. Am. Chem. Soc. 2010, 132 (15), 5437 - 5442). On the basis of structure-activity relationships of 8-34 and different binding conformations of the cis and trans isomers of 3 and 4, critical structural requirements of the NOS active site for ligand binding are revealed.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/GM049725,
http://linkedlifedata.com/resource/pubmed/grant/GM052419,
http://linkedlifedata.com/resource/pubmed/grant/GM057353,
http://linkedlifedata.com/resource/pubmed/grant/R01 GM049725-15,
http://linkedlifedata.com/resource/pubmed/grant/R01 GM052419-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7804-24
|
pubmed:dateRevised |
2011-11-14
|
pubmed:meshHeading |
pubmed-meshheading:20958055-Aminopyridines,
pubmed-meshheading:20958055-Animals,
pubmed-meshheading:20958055-Catalytic Domain,
pubmed-meshheading:20958055-Cattle,
pubmed-meshheading:20958055-Crystallography, X-Ray,
pubmed-meshheading:20958055-Drug Design,
pubmed-meshheading:20958055-Isoenzymes,
pubmed-meshheading:20958055-Models, Molecular,
pubmed-meshheading:20958055-Nitric Oxide Synthase Type I,
pubmed-meshheading:20958055-Protein Binding,
pubmed-meshheading:20958055-Protein Conformation,
pubmed-meshheading:20958055-Pyrrolidines,
pubmed-meshheading:20958055-Rats,
pubmed-meshheading:20958055-Stereoisomerism,
pubmed-meshheading:20958055-Structure-Activity Relationship
|
pubmed:year |
2010
|
pubmed:articleTitle |
Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives.
|
pubmed:affiliation |
Department of Chemistry, Center for Molecular Innovation and Drug Discovery, and Chemistry of Life Processes Institute, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, United States.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|